Drawing for VERIAN

USPTO serial 78075593

VERIAN

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
BIBBINS, ODESSA
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with VERIAN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael Schiffer

MICHAEL SCHIFFER BAXTER HEALTHCARE CORP17511 ARMSTRONG AVEIRVINE, CA 92614-5725UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005PHARMACEUTICAL PRODUCT, NAMELY, ANTIHEMOPHILIC FACTOR USED FOR THE TREATMENT OF HEMOPHILIAABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 8, 2003ABN5ABANDONMENT - AFTER PUBLICATION—
Aug 26, 2002ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jul 23, 2002PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 3, 2002NPUBNOTICE OF PUBLICATION—
Apr 13, 2002CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 23, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 26, 2001GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 26, 2001DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance